Accelerometer-derived moderate-to-vigorous-intensity physical activity: sex differences in health benefits and health equivalence between the sexes: a prospective cohort study
- 1Department of Orthopedics, Shengjing Hospital of China Medical University
- 2Department of Clinical Epidemiology, Shengjing Hospital of China Medical University
- 3Clinical Trials and Translation Center, Shengjing Hospital of China Medical University
Abstract
Background: Current physical activity guidelines are sex-neutral despite well-recognized physiological sex differences. Previous studies have reported sex differences in associations between moderate-to-vigorous-intensity physical activity (MVPA) and several health outcomes. However, sex differences in these associations and the health equivalence of MVPA between the sexes remain incompletely understood across a broad range of outcomes. Sex differences in associations between moderate-to-vigorous-intensity physical activity (MVPA) and numerous health outcomes, and the health equivalence of MVPA between the sexes, remain unexplored. We aimed to identify sex differences in associations of MVPA with mortality and incident diseases, and to quantify the health equivalence of MVPA between the sexes.
Methods: Sex-specific associations of MVPA with all-cause, cardiovascular disease (CVD), and cancer mortality, and with incident diseases were examined using Cox and Fine-Gray models. Sex differences were tested using likelihood ratio tests comparing models with and without sex-by-MVPA interaction terms. The health equivalence of MVPA between the sexes was quantified for the selected outcomes.
Results: Among 86,196 individuals (43.1% male), 5,195 deaths occurred over a median 7.93-year follow-up. For mortality, sex differences were identified in the associations of MVPA with all-cause, CVD, and cancer mortality, with median male-to-female MVPA duration ratios of 0.90, 1.37, and 0.71, respectively. For disease incidence, no sex differences remained significant after correction for multiple testing. Among incident diseases with nominally significant sex differences, MVPA was significantly associated with 12 in women only and 4 in both sexes. Exploratory health equivalence analyses yielded median male-to-female MVPA duration ratios of 2.02, 2.59, 1.87, and 1.73 for coronary atherosclerosis, other unspecified chronic ischemic heart disease, chronic airway obstruction, and gastroesophageal reflux disease, respectively.
Conclusion: For mortality, significant sex differences were identified in the associations of MVPA with all-cause, CVD, and cancer mortality. For disease incidence, no significant sex differences were identified after correction for multiple testing. The health-equivalence estimates, based on model-predicted weekly MVPA durations, should be interpreted cautiously as exploratory findings and require independent validation.
Related
- Accelerometer-derived 24-hour behavior composition and incident clinically diagnosed sleep apnoea: a prospective cohort study
- Wrist-worn accelerometer-derived activity fragmentation and cause-specific mortality in US adults: a population-based prospective cohort study
- Effects of moderate and high intensity exercise on T1/T2 balance
- Moderate-intensity exercise versus high-intensity interval training to determine the optimal training intensity for walking rehabilitation in chronic stroke (HIT-Stroke Trial 2): a study protocol for a randomized controlled trial
- High-intensity interval training and moderate-intensity continuous training versus usual care in adults with familial hypercholesterolaemia: protocol for the UPPA-FH three-arm randomised trial
BibTeX
@article{zheng2026accelerometerderived,
title = {{Accelerometer-derived moderate-to-vigorous-intensity physical activity: sex differences in health benefits and health equivalence between the sexes: a prospective cohort study}},
author = {Zihao Zheng and Haoyu Liu and Xiaoxuan Ge and Shuhe Zhang and Yuchen Wang and Yutong Wei and Peng Dong and Mufei Gao and Shanyan Gao and Yingliang Wei},
journal = {Frontiers in Public Health},
year = {2026},
month = oct,
doi = {10.3389/fpubh.2026.1966467},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1966467/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Accelerometer-derived moderate-to-vigorous-intensity physical activity: sex differences in health benefits and health equivalence between the sexes: a prospective cohort study
AU - Zihao Zheng
AU - Haoyu Liu
AU - Xiaoxuan Ge
AU - Shuhe Zhang
AU - Yuchen Wang
AU - Yutong Wei
AU - Peng Dong
AU - Mufei Gao
AU - Shanyan Gao
AU - Yingliang Wei
PY - 2026
DA - 2026/10/28
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1966467
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1966467/full
AB - Background: Current physical activity guidelines are sex-neutral despite well-recognized physiological sex differences. Previous studies have reported sex differences in associations between moderate-to-vigorous-intensity physical activity (MVPA) and several health outcomes. However, sex differences in these associations and the health equivalence of MVPA between the sexes remain incompletely understood across a broad range of outcomes. Sex differences in associations between moderate-to-vigorous-intensity physical activity (MVPA) and numerous health outcomes, and the health equivalence of MVPA between the sexes, remain unexplored. We aimed to identify sex differences in associations of MVPA with mortality and incident diseases, and to quantify the health equivalence of MVPA between the sexes. Methods: Sex-specific associations of MVPA with all-cause, cardiovascular disease (CVD), and cancer mortality, and with incident diseases were examined using Cox and Fine-Gray models. Sex differences were tested using likelihood ratio tests comparing models with and without sex-by-MVPA interaction terms. The health equivalence of MVPA between the sexes was quantified for the selected outcomes. Results: Among 86,196 individuals (43.1% male), 5,195 deaths occurred over a median 7.93-year follow-up. For mortality, sex differences were identified in the associations of MVPA with all-cause, CVD, and cancer mortality, with median male-to-female MVPA duration ratios of 0.90, 1.37, and 0.71, respectively. For disease incidence, no sex differences remained significant after correction for multiple testing. Among incident diseases with nominally significant sex differences, MVPA was significantly associated with 12 in women only and 4 in both sexes. Exploratory health equivalence analyses yielded median male-to-female MVPA duration ratios of 2.02, 2.59, 1.87, and 1.73 for coronary atherosclerosis, other unspecified chronic ischemic heart disease, chronic airway obstruction, and gastroesophageal reflux disease, respectively. Conclusion: For mortality, significant sex differences were identified in the associations of MVPA with all-cause, CVD, and cancer mortality. For disease incidence, no significant sex differences were identified after correction for multiple testing. The health-equivalence estimates, based on model-predicted weekly MVPA durations, should be interpreted cautiously as exploratory findings and require independent validation.
SN - 2296-2565
ER -